A2A Pharmaceuticals, Inc. - May 31, 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Stock symbol
BMEA
Transactions as of
May 31, 2023
Transactions value $
-$4,263,915
Form type
4
Date filed
6/2/2023, 05:00 PM
Previous filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale -$2.54M -75K -2.07% $33.81 3.55M May 31, 2023 Direct F1
transaction BMEA Common Stock Sale -$1.73M -50K -1.41% $34.56 3.5M Jun 1, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

A2A Pharmaceuticals, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request.
F2 A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request.